http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109875999-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5025 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2018-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-109875999-B |
| titleOfInvention | Ponatinib in KIT-mutant malignant melanoma |
| abstract | The invention discloses the application of ponatinib in KIT mutant malignant melanoma. Specifically, the present invention provides use in KIT mutant malignant melanoma of V560D, K642E, and D816V. Experiments found that low-dose ponatinib can inhibit KIT-mutant malignant melanoma, and with the increase of treatment days, its inhibitory effect remains effective and stable. |
| priorityDate | 2018-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 274.